Axonics

Focus: Axonics is a medical device company specializing in sacral neuromodulation systems for overactive bladder and urinary incontinence. The company operates in the specialized neuromodulation device market with a focused product portfolio.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Axonics

AI assessmentNot Hiring

No open roles listed right now. Follow Axonics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Sacral Neuromodulation System

Overactive Bladder

Growth

Lead product validated across 8 clinical trials, representing the company's core revenue driver in the sacral neuromodulation space.

Pipeline & Clinical Trials

Help build intelligence for Axonics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused medical device portfolio in high-need urology market with established clinical evidence across 9 active trials
Specialized expertise in sacral neuromodulation positions the company as a defined player in a growing therapeutic area
Device-based business model offers different career trajectory than traditional pharma with emphasis on clinical validation and reimbursement strategy

Watch Out For

Currently zero active job openings suggests limited near-term hiring and potential organizational constraints
Missing financial data (revenue, R&D spend, cash position) creates visibility gap on company stability and growth trajectory
Device-only portfolio lacks pipeline diversification; vulnerability if lead product faces reimbursement or regulatory headwinds

Generated by Claude from Axonics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Axonics External Trial System

Urinary Urge Incontinence

N/A

Clinical Trials (1)

NCT07335484Aquarius Pilot Study to Evaluate the New Axonics Trial System

N/A

Axonics SNM System INS Model 5101

Fecal Incontinence

N/A

Clinical Trials (1)

NCT07499258Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

N/A

Axonics System

Overactive Bladder Syndrome

N/A

Clinical Trials (1)

NCT05543382Cycling Study With the Axonics System

N/A

Axonics SNM System INS Model 5101

Urinary Urge Incontinence (UUI)

N/A

Clinical Trials (1)

NCT06789406PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

N/A

Axonics SNM System

Urinary Urge Incontinence (UUI)

N/A

Clinical Trials (1)

NCT06186765F15 Recharge Free Axonics SNM System Clinical Study

N/A

Axonics SNM System

Overactive Bladder

N/A

Clinical Trials (1)

NCT06511141Sacral Neuromodulation for Male Overactive Bladder (MOAB)

N/A

Sacral Neuromodulation System

Overactive Bladder

N/A

Clinical Trials (3)

NCT03327948Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt

N/A

NCT02620410Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB)

N/A

NCT05064384Axonics SacRal NeuromodulaTIon System RegisTRY Study

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 9 clinical trials

Top TAs: Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

1 pipeline

Marketed

Pipeline